SCHEMBL16372003

SCHEMBL16372003

C[C](C)Cc1n[nH]cc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18074291 0.83 AGBL2 (0.33)
SCHEMBL6620138 0.77
SCHEMBL15555715 0.77 HCAR2 (0.39)
SCHEMBL3587690 0.76 SMN1; SMN2 (0.46)
Hydrochloric Acid SCHEMBL3587687 0.75 SMN1; SMN2 (0.45)
SCHEMBL2028609 0.75
SCHEMBL17785640 0.74
Phosphoric Acid SCHEMBL2026236 0.74 PGK1 (0.31)
SCHEMBL17785870 0.73
SCHEMBL19687235 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019478-A1 FUSED PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS Vertex Pharmaceuticals Inc. (US) 2016-05-18 EP disclosed
WO-2015006280-A1 FUSED PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-01-15 WO disclosed